Antibiotic of Choice for Pleural Infection
For community-acquired pleural infection, use cefuroxime 1.5 g IV three times daily PLUS metronidazole 400-500 mg three times daily as first-line empirical therapy; for hospital-acquired infection, use piperacillin-tazobactam 4.5 g IV four times daily. 1
Treatment Algorithm Based on Origin of Infection
Community-Acquired Pleural Infection
The BTS guidelines establish beta-lactams as the drugs of choice due to excellent pleural space penetration 1. Coverage must include both aerobic pathogens (Pneumococcus, Staphylococcus aureus, Haemophilus influenzae) AND anaerobes, as anaerobes are present in up to 75% of cases 2.
Preferred IV regimens:
- Cefuroxime 1.5 g three times daily IV + metronidazole 400 mg three times daily orally OR 500 mg three times daily IV 1
- Benzyl penicillin 1.2 g four times daily IV + ciprofloxacin 400 mg twice daily IV (may reduce C. difficile risk) 1
- Meropenem 1 g three times daily IV + metronidazole 400-500 mg three times daily 1
Oral step-down options:
- Amoxicillin-clavulanate 1 g/125 mg three times daily 1
- Amoxicillin 1 g three times daily + metronidazole 400 mg three times daily 1
- Clindamycin 300 mg four times daily (single-agent coverage of both aerobes and anaerobes) 1
Hospital-Acquired Pleural Infection
Requires broader spectrum coverage for nosocomial pathogens including Staphylococcus aureus and aerobic gram-negative bacilli 1, 2.
Preferred IV regimens:
- Piperacillin-tazobactam 4.5 g four times daily IV 1
- Ceftazidime 2 g three times daily IV 1
- Meropenem 1 g three times daily IV ± metronidazole 1
Critical Pharmacokinetic Considerations
Avoid aminoglycosides - they have poor pleural space penetration and become inactive in the acidic, purulent environment of infected pleural fluid 1. Recent pharmacokinetic data confirms that amoxicillin, metronidazole, piperacillin-tazobactam, and clindamycin all achieve pleural fluid concentrations equivalent to blood levels and well above minimum inhibitory concentrations 3. However, co-trimoxazole fails to achieve adequate pleural penetration and should be avoided 3.
Culture-Directed Therapy
Always obtain pleural fluid for culture before starting antibiotics, but do not delay treatment 1. Positive cultures are obtained in only 56% of cases 4, so empirical therapy is frequently necessary. When cultures return positive, narrow antibiotics based on sensitivities while maintaining anaerobic coverage if polymicrobial infection is suspected 1.
Important Caveats
- No intrapleural antibiotic administration is needed - systemic antibiotics achieve adequate pleural concentrations 1
- Adjust doses appropriately in renal or hepatic failure 1
- A significant proportion of both aerobes and anaerobes may be penicillin-resistant, necessitating beta-lactamase inhibitor coverage 1
- Macrolides should only be added if Legionella is specifically suspected (rare cause of empyema) 1
- Mycoplasma pneumoniae causes small reactive effusions that typically resolve with pneumonia treatment 1
Duration and Escalation
Continue antibiotics throughout drainage therapy. If patients fail to improve after approximately 7 days of drainage plus antibiotics, surgical consultation is appropriate 1. The guidelines emphasize that inappropriate antibiotic selection contributes to progression of pleural infection and increased mortality 1.